DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Pyridoxal Phosphate is an investigational drug.
There have been 4 clinical trials for Pyridoxal Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on July 1st 2011.
The most common disease conditions in clinical trials are Movement Disorders, Dyskinesias, and Protoporphyria, Erythropoietic. The leading clinical trial sponsors are University of Alabama at Birmingham, Beersheva Mental Health Center, and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
There are two US patents protecting this investigational drug and twenty international patents.
Recent Clinical Trials for Pyridoxal Phosphate
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||Icahn School of Medicine at Mount Sinai||N/A|
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)||N/A|
|Effect of Isoniazid on Protoporphyrin Levels in Erythropoietic Protoporphyria||University of Alabama at Birmingham||N/A|
Top disease conditions for Pyridoxal Phosphate
Top clinical trial sponsors for Pyridoxal Phosphate
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Pyridoxal Phosphate||Start Trial||Bone delivery conjugates and method of using same to target proteins to bone||Alexion Pharmaceuticals, Inc. (New Haven, CT)||Start Trial|
|Pyridoxal Phosphate||Start Trial||Particle detecting device||AZBIL CORPORATION (Chiyoda-ku, JP)||Start Trial|
|Pyridoxal Phosphate||Start Trial||Dietary supplement and methods of use||Inovobiologic Inc. (Calgary, CA)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|Pyridoxal Phosphate||Austria||505551||2024-04-21||Start Trial|
|Pyridoxal Phosphate||Australia||2005235635||2024-04-21||Start Trial|
|Pyridoxal Phosphate||Canada||2559228||2024-04-21||Start Trial|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|